Laurion Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Laurion Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-117,266	Closed	-$6.32M	–	1900
2017 Q4	$6.32M	Buy	117,266 +96,147	+455%	+$5.26M	0.03%	451
2017 Q3	$1.21M	Sell	21,119 -19,109	-48%	-$1.12M	0.01%	915
2017 Q2	$2.42M	Sell	40,228 -956,106	-96%	-$54.4M	0.01%	756
2017 Q1	$54.3M	Buy	+996,334	New	+$49.1M	0.41%	55

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Laurion Capital Management's BIVV Position: Q1 2018 in Review

Laurion Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 117,266 shares — an estimated $6.32M sold.

Laurion Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $54.3M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Laurion Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Laurion Capital Management sold 117,266 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6.32M.
Laurion Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Laurion Capital Management's Bioverativ Inc. Common Stock position peaked at $54.3M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Laurion Capital Management's 13F filing for Q1 2018, filed 14 May 2018.